医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ZOLL Medical’s Advanced Defibrillators Win Five-Star World of Safety & Health Asia Award 2020

2021年01月06日 AM11:00
このエントリーをはてなブックマークに追加


 

CHELMSFORD, Mass.

ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that its ZOLL AED 3® and ZOLL AED 3 BLS automated external defibrillators (AEDs) were recognized by the World of Safety & Health Asia (WSHAsia) in its inaugural New & Innovative Solutions Awards program. As the only products to receive a five-star rating, the ZOLL defibrillators were recognized for their unrivaled smart technology and the industry’s shortest interval between compressions and shock delivery.

“We’re honored to be recognized by World of Safety & Health Asia for our Real CPR Help® and RapidShock™ technologies. We are committed to delivering life-saving AEDs that enable bystanders and rescuers to act quickly and with confidence in medical emergencies,” said Elijah A. White, President of ZOLL Resuscitation. “Research shows that real-time CPR feedback, along with training, more than doubles cardiac arrest survival rates, and we’re dedicated to doing our part to deliver advanced CPR feedback technology, ease of use, and reliability to support both professional and lay rescuers through each step of the process.”

WSHAsia’s New & Innovative Solution Awards recognize excellence in products and services that aim to improve workplace safety and health. The entries were evaluated by a panel of five renowned figures in the safety and health industry from across the Asia Pacific region. A five-star rating denotes an approval from each of the five panel judges.

“We are impressed by the innovative AEDs from ZOLL Medical, with their remarkably short pre-shock pauses between compression cycles, the shortest in the industry,” said Raymond Wat, founder of World of Safety & Health Asia. “The ZOLL AED 3 and ZOLL AED 3 BLS were designed with smart technologies that support all rescuers and automated monitoring features with WiFi connectivity to enhance emergency readiness.”

ZOLL AED 3
The intuitive design and enhanced features of the ZOLL AED 3 defibrillator give unexpected heroes both the confidence and the knowledge needed to treat sudden cardiac arrest (SCA). Proven Real CPR Help technology helps rescuers deliver high-quality CPR with real-time, guideline-driven feedback on the quality of chest compressions. It also features a full-color display with vivid rescue images, a CPR cycle timer, and a large color bar gauge that shows CPR compression depth.

The universal design of the CPR Uni-padz® electrodes allows rescuers to treat both adult and pediatric victims of SCA with the same set of pads by simply activating the child mode. WiFi connectivity enables automatic reporting of device status, giving organizations and rescuers confidence the AED is ready to use when needed. It also provides the ability to quickly access and transmit cardiac arrest event data to medical professionals.

ZOLL AED 3 BLS
The ZOLL AED 3 BLS defibrillator includes all the features of the ZOLL AED 3 defibrillator, but also provides in-depth rescue support for professional rescuers. A CPR Dashboard™ on the device shows elapsed time, CPR cycle countdown, shocks delivered, and ECG. Using RescueNet® CaseReview, detailed rescue performance data can be exported quickly and easily via USB or transferred directly over WiFi. Data can be evaluated and used to improve future responder performance. The ZOLL AED 3 BLS not only guides rescuers in delivering high-quality CPR, but is also one of the fastest AEDs in the industry at delivering a shock after chest compressions stop — two critical components to increasing a victim’s chance of survival.

ZOLL RAPIDSHOCK ANALYSIS*
The ZOLL AED 3 and ZOLL AED 3 BLS defibrillators both include ZOLL’s RapidShock Analysis technology, with the industry’s shortest pause for analysis and the fastest time to shock. It can analyze a patient’s heart rhythm in three seconds, followed by delivery of the shock in as little as five seconds.

About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, supersaturated oxygen therapy, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.

About Asahi Kasei
The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber business, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 40,000 employees around the world, the company contributes to sustainable society by providing solutions to the world’s challenges through its three business sectors of Material, Homes, and Health Care. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. For more information, visit www.asahi-kasei.com.

*RapidShock Analysis technology is not available in the United States.

©2021 ZOLL Medical Corporation. All rights reserved. CPR Dashboard, RapidShock, Real CPR Help, RescueNet, Uni-padz, ZOLL, and ZOLL AED 3 are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All other trademarks are the property of their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210105005974/en/

CONTACT

Edna Kaplan

KOGS Communication

+1 (617) 974-8659

kaplan@kogspr.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • ERS Genomicsと日本エスエルシーがCRISPR/Cas9ライセンス契約に署名
  • Mirum Pharmaceuticals and GC Pharma Enter into Exclusive Licensing Agreement to Develop and Commercialize Maralixibat for Rare Liver Diseases in South Korea
  • Dr. Revati Shreeniwas Joins ImmunoMet Therapeutics as Chief Medical Officer
  • Adagio Therapeutics Partners with Biocon Biologics to Bring Potent and Broadly Neutralizing COVID-19 Antibody Treatment to Patients in India and Select Emerging Markets
  • Twist Bioscience社がMOLCURE社の人工知能技術を導入し、抗体医薬品の探索を強化